RenovaCare Chairman Discusses 2020 Highlights and Provides 2021 Outlook

Roseland, NJ – December 22, 2020 – RenovaCare, Inc. (Symbol: RCAR;, a clinical-stage developer of patented technologies for spraying self-donated stem cells for the regeneration of skin and other organs and tissues, announced today that it has issued the following year-end letter from its Chairman and CEO, Alan L. Rubino to the Company’s stockholders and interested parties: